logo BDSP

Base documentaire

  1. Economic impact of inappropriate histamine2-receptor antagonist use.

    Article - En anglais

    Histamine2 (H2) - receptor antagonists are widely prescribed for a variety of acid-mediated gastrointestinal disorders.

    The objective of the present study was to quantify the frequency of inappropriate H2-receptor antagonist use and its economic impact in patients who were admitted to a critical care bed at our hospital and followed as outpatients for I year.

    Eighty-eight (72%) of 123 patients admitted to the coronary care unit (CCU) or the intensive care unit over a 14-day period received H2-receptor antagonists.

    Forty-five (51%) of the 88 patients did not have a documented indication for H2-receptor antagonist therapy.

    Most of the patients without indications were admitted to the CCU for cardiac diagnoses.

    Thirty-eight patients (43%) were discharged on oral H2-receptor antagonist therapy.

    Twenty (53%) of the 38 patients had no documented indication for therapy ; 17 of these patients continued H2-receptor antagonist therapy for 1 year, whereas the remaining 3 patients received therapy for 1,2, and 3 months, respectively.

    The cost of therapy for the 45 patients receiving inappropriate therapy during hospitalization was $5,084.31.

    Outpatient costs for the 20 patients remaining on inappropriate therapy was $8,619.75.

    The total cost of inappropriate therapy was $13,704.06.

    If data collected during this 2-week period were extrapolated to 1 year, the projected annual cost of inappropriate therapy would be $356,305.56. (...)

    Mots-clés Pascal : Récepteur histaminergique H2, Antiacide, Antiulcéreux, Antagoniste, Antihistaminique, Analyse avantage coût, Analyse coût efficacité, Efficacité traitement, Homme, Economie santé, Etude critique, Utilisation, Hôpital, Unité soin intensif, Analyse économique

    Mots-clés Pascal anglais : H2 Histamine receptor, Antiacid, Antiulcer agent, Antagonist, Antihistaminic, Cost benefit analysis, Cost efficiency analysis, Treatment efficiency, Human, Health economy, Critical study, Use, Hospital, Intensive care unit, Economic analysis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0053555

    Code Inist : 002B30A01C. Création : 14/05/1998.